Quinoline, 7-chloro-4-[4-[(2,4-dinitrophenyl)sulfonyl]-1-piperazinyl]-, 50mg

2-Fluoro-7,8,9,10-tetrahydro-6H-cyclohepta[b]quinoline-11-carboxylic acid, 250mg

2,3-Bis(bromomethyl)quinoxaline, 95.0%, 250mg

1-(4-Methylnaphthyl) trifluoromethyl ketone, 97.0%, 2g

3-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95.0%, 100mg

2-Aminopentane>97.0%(GC)25mL

5-(tetrahydro-2-furanyl)-1,3,4-oxadiazol-2-amine, 95.0%, 5g

(2S)-1-BOC-2-METHYLPYRROLIDINE-2-METHANAMINE, 95.0%, 250mg

Nalpha-(5-Fluoro-2,4-dinitrophenyl)-L-alaninamide [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)1g

2-(1-Oxo-1,3-dihydro-isoindol-2-yl)-2-phenyl-N-thiazol-2-yl-acetamide, 95%, 250mg

3,5-Dichloropicolinaldehyde, 95.0%, 5g

(1-Methylpiperidin-4-yl)methanol, 99.00%, 5g

2-Amino-4-(trifluoromethyl)benzaldehyde, 98%, 250mg